Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

859
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
859
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

7.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Hyperglycemia01:29

Hyperglycemia

34
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
34

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.

The New England journal of medicine·2026
Same author

A Catalog of the Pathogenic Variants in ABCG5 and ABCG8 and Clinical Features in Sitosterolemia.

Journal of atherosclerosis and thrombosis·2026
Same author

A Comparative Study of Carotid Ultrasound Findings in Patients With and Without Familial Hypercholesterolemia.

Cureus·2025
Same author

Roxadustat Activates Thyroid Hormone Receptors α and β at Clinically Relevant Concentrations.

Cureus·2025
Same author

C-reactive protein modulates lipid mediators in a pro-inflammatory direction.

Journal of inflammation (London, England)·2025
Same author

Rspo3-mediated metabolic liver zonation regulates systemic glucose metabolism and body mass in mice.

PLoS biology·2025

Related Experiment Video

Updated: May 6, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

3.7K

[Endogenous hypertriglyceridemia].

Kazuhisa Tsukamoto1

  • 1Department of Metabolism, Diabetes and Nephrology, Aizu Medical Center, Fukushima Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 12, 2013
PubMed
Summary
This summary is machine-generated.

Endogenous hypertriglyceridemia involves high blood VLDL-triglycerides due to liver overproduction and reduced vessel catabolism. Polygenic factors are suspected, and genome-wide association studies may clarify the causes of this condition.

More Related Videos

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

3.4K
Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.9K

Related Experiment Videos

Last Updated: May 6, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

3.7K
The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

3.4K
Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

3.9K

Area of Science:

  • Metabolic disorders
  • Genetics
  • Cardiovascular disease risk factors

Context:

  • Endogenous hypertriglyceridemia is defined by elevated blood VLDL-triglycerides.
  • It shares metabolic features with insulin resistance, including increased VLDL production and decreased VLDL-TG catabolism.
  • Familial and idiopathic hypertriglyceridemia are key subtypes.

Purpose:

  • To explore the underlying causes of endogenous hypertriglyceridemia.
  • To highlight the role of genetic factors in the development of hypertriglyceridemia.
  • To discuss the potential of advanced genetic analysis in understanding this condition.

Summary:

  • Endogenous hypertriglyceridemia is characterized by elevated VLDL-triglycerides.
  • Proposed causes include increased hepatic VLDL production and impaired vascular VLDL-triglyceride catabolism, mirroring insulin resistance features.
  • While genetic factors are implicated, they remain largely unidentified, suggesting a polygenic basis.

Impact:

  • Advances in genetic analytical methods, such as genome-wide association studies (GWAS), are expected to provide a comprehensive understanding of endogenous hypertriglyceridemia.
  • This research could lead to improved diagnostic and therapeutic strategies for managing hypertriglyceridemia and associated cardiovascular risks.
  • Understanding the genetic architecture is crucial for personalized medicine approaches.